Next Article in Journal
There Is Treasure Everywhere: Reductive Plastid Evolution in Apicomplexa in Light of Their Close Relatives
Next Article in Special Issue
Proinflammatory Action of a New Electronegative Low-Density Lipoprotein Epitope
Previous Article in Journal
Aortic Oxidative Stress, Inflammation and DNA Damage Following Pulmonary Exposure to Cerium Oxide Nanoparticles in a Rat Model of Vascular Injury
Previous Article in Special Issue
Genome-Wide Association Study of Metabolic Syndrome Reveals Primary Genetic Variants at CETP Locus in Indians
Open AccessReview

Changes in Mitochondrial Genome Associated with Predisposition to Atherosclerosis and Related Disease

1
Laboratory of Gene Therapy, Biocad Biotechnology Company, Saint-Petersburg, Strelnya 198515, Russia
2
Federal Scientific Clinical Center for Resuscitation and Rehabilitation, Moscow 109240, Russia
3
Institute of Cellular and System Medicine, National Health Research Institutes, 35 Keyan Road, Zhunan Town, Miaoli County 35053, Taiwan
4
Laboratory of Medical Genetics, Russian Cardiology Research and Production Complex, Moscow, Russia
5
Institute for Atherosclerosis Research, Skolkovo Innovative Center, Moscow 121609, Russia
6
Institute of Human Morphology, Moscow 117418, Russia
7
Institute of General Pathology and Pathophysiology, Moscow 125315, Russia
*
Author to whom correspondence should be addressed.
Biomolecules 2019, 9(8), 377; https://doi.org/10.3390/biom9080377
Received: 2 June 2019 / Revised: 8 August 2019 / Accepted: 13 August 2019 / Published: 18 August 2019
Atherosclerosis-related cardiovascular diseases remain the leading cause of morbidity and mortality, and the search for novel diagnostic and therapeutic methods is ongoing. Mitochondrial DNA (mtDNA) mutations associated with atherosclerosis represent one of the less explored aspects of the disease pathogenesis that may bring some interesting opportunities for establishing novel molecular markers and, possibly, new points of therapeutic intervention. Recent studies have identified a number of mtDNA mutations, for which the heteroplasmy level was positively or negatively associated with atherosclerosis, including the disease at its early, subclinical stages. In this review, we summarize the results of these studies, providing a list of human mtDNA mutations potentially involved in atherosclerosis. The molecular mechanisms underlying such involvement remain to be elucidated, although it is likely that some of them may be responsible for the increased oxidative stress, which plays an important role in atherosclerosis. View Full-Text
Keywords: atherosclerosis; mitochondria; mtDNA; mutations; heteroplasmy; molecular markers atherosclerosis; mitochondria; mtDNA; mutations; heteroplasmy; molecular markers
MDPI and ACS Style

Volobueva, A.; Grechko, A.; Yet, S.-F.; Sobenin, I.; Orekhov, A. Changes in Mitochondrial Genome Associated with Predisposition to Atherosclerosis and Related Disease. Biomolecules 2019, 9, 377.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop